The Use of Last-Line Antibiotics for the Treatment of COVID-19 Is a Risk to Disarm Humanity Against Future Antibiotic-Resistant Infectious Diseases

Hosseininasab, Seyed Soheil; Gorji, Mahdieh; Hosseini, Seyyedeh Sanaz; Moghadam, Majid Taati

doi:10.1097/ipc.0000000000001272

Cited by 3 publications

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…According to the studies conducted, inorganic nanoparticles such as metal nanoparticles and organic nanoparticles such as polymer nanoparticles, liposomes, ferritin, and micelles have been used to treat various medical diseases 15–18 . Today, various researchers around the world are looking for new ways to treat various bacterial diseases 19–26 . Metal nanoparticles are widely utilized for different biological and medical applications and are potential candidates for the treatment and detection of pathogens, which can be more associated with their unique effects, including their size and shape 27–29 .…”

Section: Introductionmentioning

confidence: 99%

Nanotechnology, a novel strategy in detecting Streptococcus agalactiae, and its antibacterial, antibiofilm, and antiquorum sensing properties

Dousari,

Amirheidari,

Dousari

et al. 2023

Applied Organom Chemis

View full text Add to dashboard Cite

Streptococcus agalactiae or group B streptococcus is the cause of various infections in pregnant women and non‐pregnant adults with immunodeficiency, especially diabetics and infants. This bacterium can cause serious infections such as endocarditis, septicemia, meningitis, pneumonia, and urinary tract infections with a high mortality rate. Nowadays, the use of nanoparticles can play a central role in the management of such diseases due to their remarkable biocompatibility and distinct physicochemical characteristics. Nanoparticles are synthesized by various methods such as biological, chemical, and physical, and each has its own unique properties. Nanoparticles have antibacterial, anti‐biofilm, and antiquorum sensing properties in in vitro and in vivo conditions on human pathogens through different pathways. Different nanoparticles displayed that in addition to detecting S. agalactiae, it has antibacterial, antibiofilm, and antiquorum sensing effects on this bacterium. Therefore, the purpose of this review is to investigate different nanoparticles for the detection and effects of antibacterial, anti‐biofilm, and anti‐infestation assays against the human pathogen S. agalactiae.

show abstract

Section: Introductionmentioning

confidence: 99%

Nanotechnology, a novel strategy in detecting Streptococcus agalactiae, and its antibacterial, antibiofilm, and antiquorum sensing properties

Dousari,

Amirheidari,

Dousari

et al. 2023

Applied Organom Chemis

View full text Add to dashboard Cite

show abstract

Prediction of tsunami of resistance to some antibiotics is not far‐fetched which used during COVID‐19 pandemic

Hosseini,

Ahmed Hamad,

Mohseni

et al. 2023

Clinical Laboratory Analysis

View full text Add to dashboard Cite

One of the most tragic events in recent history was the COVID‐19 outbreak, which has caused thousands of deaths. A variety of drugs were prescribed to improve the condition of patients, including antiparasitic, antiviral, antibiotics, and anti‐inflammatory medicines. It must be understood, however, that COVID‐19 is like a tip of an iceberg on the ocean, and the consequences of overuse of antibiotics are like the body of a mountain under water whose greatness has not yet been determined for humanity, and additional study is needed to understand them. History of the war between microbes and antimicrobial agents has shown that microbes are intelligent organisms that win over antimicrobial agents over time through many acquired or inherent mechanisms. The key terms containing “COVID‐19,” “Severe acute respiratory syndrome coronavirus‐2,” “SARS‐CoV2,” “Antibiotic Resistance,” “Coronavirus,” “Pandemic,” “Antibiotics,” and “Antimicrobial Resistance” were used for searching in PubMed, Scopus, and Google Scholar databases. The COVID‐19 pandemic has resulted in an increased prescription of antibiotics. Infections caused by secondary or co‐bacterial infections or beneficial bacteria in the body can be increased as a result of this amount of antibiotic prescription and exposure to antibiotics. Antibiotic resistance will likely pose a major problem in the future, especially for last resort antibiotics. In order to address the antibiotic resistance crisis, it is imperative that researchers, farmers, veterinarians, physicians, public and policymakers, pharmacists, other health and environmental professionals, and others collaborate during and beyond this pandemic.

show abstract

Genetically engineered phages and engineered phage-derived enzymes to destroy biofilms of antibiotics resistance bacteria

Eghbalpoor,

Gorji,

Alavigeh

et al. 2024

Heliyon

View full text Add to dashboard Cite

The Use of Last-Line Antibiotics for the Treatment of COVID-19 Is a Risk to Disarm Humanity Against Future Antibiotic-Resistant Infectious Diseases

Cited by 3 publications

References 11 publications

Nanotechnology, a novel strategy in detecting Streptococcus agalactiae, and its antibacterial, antibiofilm, and antiquorum sensing properties

Nanotechnology, a novel strategy in detecting Streptococcus agalactiae, and its antibacterial, antibiofilm, and antiquorum sensing properties

Prediction of tsunami of resistance to some antibiotics is not far‐fetched which used during COVID‐19 pandemic

Genetically engineered phages and engineered phage-derived enzymes to destroy biofilms of antibiotics resistance bacteria

Contact Info

Product

Resources

About